drugset / Trial / NCT00612417
Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402
RandomizedParallel-groupDouble-blind
Summary
Single administration of recombinant FVIII/placebo in healthy male subjects who have been treated with a single dose of anti-factor VIII antibody, TB-402
Timeline
- Start
- 2008-01
- Primary completion
- 2008-03
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | turoctocog alfa | Protein / enzyme biologic | — | — |
| Background | TB-402 | Monoclonal antibody | — | — |
Indications
No indication recorded.